SCHEMBL30883370

SCHEMBL30883370

COC(=O)c1c(C(=O)OC)c2cc(N)ccn2c1C(=O)c1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPT P10636 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30883372 0.88 KDM4E (0.51) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL30883371 0.88 KDM4E (0.51) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL27211514 0.87 CA1 (0.42) KDM4ESMN1; SMN2HPGDCA1CA2
SCHEMBL28103002 0.75 KDM4E (0.49) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL26665761 0.72 KDM4E (0.59) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL24748942 0.71 CA1 (0.43) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL26665762 0.71 KDM4E (0.56) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL26665755 0.71 KDM4E (0.56) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL26665773 0.71 KDM4E (0.56) KDM4ESMN1; SMN2HPGDHTTNPSR1
SCHEMBL26665768 0.71 HTT (0.61) KDM4ESMN1; SMN2HPGDHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents King Faisal University (SA) 2024-05-07 — — US claimed
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents King Faisal University (SA) 2024-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents BET1, INMT, IDO1 KDM4E 878/4885SMN1; SMN2 4849/4885HPGD 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback